U.S. Biotech Stock News

Cheesecake Factory stock overview Cheesecake Factory (CAKE) shares recently closed at US$54.70, with the stock showing mixed short term returns. This includes a 0.6% move over the past day, a 4.0% decline over the week, and a 15.6% decline over the month. See our latest analysis for Cheesecake Factory. The recent 15.6% 1-month share price decline contrasts with a 3.6% year-to-date share price gain and a 9.7% 1-year total shareholder return, suggesting fading near-term momentum while...

FactSet Research Systems (FDS) has just posted Q2 2026 results with revenue of US$611.0 million and basic EPS of US$3.60, as investors weigh these figures against ongoing earnings expectations. The company has seen quarterly revenue move from US$570.7 million in Q2 2025 to US$611.0 million in Q2 2026, while basic EPS over the same quarters shifted from US$3.81 to US$3.60, presenting a picture of higher top line with changing earnings per share. With a trailing net profit margin of 24.5% and...

Recent performance snapshot Apollo Global Management (APO) has drawn fresh attention after a recent move in its share price, with the stock last closing at $111.42 and showing mixed returns across different time frames. See our latest analysis for Apollo Global Management. The recent 1 month share price return of 6.52% stands against a 90 day share price decline of 23.03%, while the 5 year total shareholder return of 159.11% points to a much stronger longer term record. This suggests that...

In March 2026, Moog Inc. announced it had awarded Redwire Corporation a US$12.8 million contract to deliver Extensible Low-Profile Solar Array (ELSA) wings for integration into Moog’s METEOR satellite bus, supporting a Low Earth Orbit mission for an undisclosed national security customer. Moog’s decision to baseline Redwire’s ELSA solar array wings as a standard component on its METEOR ESPA-Grande satellite bus highlights potential recurring demand for Redwire’s power systems on future...

Opera (NasdaqGS:OPRA) has introduced MCP Connector for its AI focused Opera Neon browser, allowing external AI clients such as ChatGPT and Claude to access live browser sessions and perform in browser actions in real time. See our latest analysis for Opera. After a strong 4.85% one-day share price return to US$14.26, Opera still sits on a 30-day share price return of an 11.10% decline. Its 3-year total shareholder return of 62.03% and 5-year total shareholder return of 70.41% point to gains...

Chipotle Mexican Grill recently marked National Burrito Day with the return of its Burrito Vault: Double Protein Edition game, offering over US$2.00 million in prizes and a US$0 delivery fee on digital orders placed via its app and website on April 2. This large-scale digital promotion highlights Chipotle’s focus on using gamified rewards and delivery incentives to deepen engagement among Chipotle Rewards members in the US and Canada. We’ll now examine how this gamified, rewards-based...

New pneumatic free crate systems spotlight UFP Industries stock UFP Industries (UFPI) drew fresh investor attention after UFP Packaging launched its Slot-Lock and Clamp-Lock 100 crate systems, expanding a pneumatic free lineup focused on workplace safety, reuse, and lower packaging waste. See our latest analysis for UFP Industries. At a share price of $92.12, UFP Industries has seen a 2.38% 1 day share price return and a 1.18% 90 day share price return. Its 1 year total shareholder return of...

Why Trustmark is on investors’ radar today Trustmark (TRMK) is drawing attention after recent trading left the share price around $42.14, with returns over the past year, past 3 months and past month giving investors fresh context for reassessing the regional bank. See our latest analysis for Trustmark. While the share price has been relatively steady in the very short term, the 90 day share price return of 8.19% sits alongside a 1 year total shareholder return of 25.16% and a 3 year total...

This article examines whether ImmunityBio at US$7.65 still offers value or if most of the opportunity is already reflected in the price, by breaking down what the current market level may be implying. The stock has had a mixed run, with a 3.2% return over the last 7 days, a 21.8% decline over 30 days, a 278.7% return year to date and 158.4% over the past year, while the 5 year return sits at a 59.3% decline and the 3 year return is 355.4%. Recent coverage has focused on ImmunityBio's...

DENTSPLY SIRONA recently reported softer quarterly results, with average constant-currency revenue falling 5.5% year-on-year over the past two years and return on invested capital remaining negative. This combination of shrinking revenues and declining returns on invested capital highlights operational challenges that may be linked to intensifying competition or market saturation in key categories. We’ll now examine how DENTSPLY SIRONA’s continued revenue declines and weakening returns could...

In late March 2026, Pediatrix Medical Group, Inc. expanded its presence in Middle Tennessee by acquiring Tennessee Maternal-Fetal Medicine in a cash deal, integrating five Greater Nashville locations and a ten-provider team under the Maternal-Fetal Medicine Specialists of Tennessee banner, with the transaction expected to be immediately accretive to earnings. This move reinforces Pediatrix’s focus on high-acuity maternal-fetal care and broader regional coverage, potentially enhancing its...

Century Communities, Inc. has recently marked or announced the opening of several new home communities across California, Kentucky, Arizona, Georgia, Colorado and Texas, featuring a mix of single-family homes and townhomes with modern finishes, open-concept layouts and price points ranging from the mid US$200,000s to the high US$700,000s. A key thread across these launches is the continued rollout of Century Communities’ online homebuying platform, which enables buyers in multiple states to...

Baxter International (NYSE:BAX) has introduced the IV Verify Line Labeling System, an automated IV line labeling solution. The system is developed in an exclusive partnership with Vigilant Software to support medication safety and nurse workflow automation. The launch targets long running challenges around inconsistent IV labeling and related medication errors in clinical settings. Baxter International is putting fresh focus on clinician centric products, with IV Verify arriving as a...

Wondering whether Royal Gold's share price around US$254.49 reflects its true worth, or if there is a gap between price and value that matters to you as a shareholder. The stock has delivered a 56.4% return over the last year and 93.8% over three years, while the past 30 days show a 15.1% decline alongside an 11.9% gain over the last week and a 15.1% return year to date. Recent moves in the share price sit against a backdrop of ongoing interest in precious metals exposure, as investors weigh...

Sea (NYSE:SE) has drawn investor attention after recent trading left the share price at US$82.81, with returns over the past month and past 3 months showing double digit declines from earlier levels. See our latest analysis for Sea. That 1-day share price return of 5.75% comes after a 30-day share price decline of 23.64% and a year-to-date share price loss of 37.02%. The 1-year total shareholder return is down 37.48%, suggesting recent momentum is still fading despite the latest bounce. If...

If you are wondering whether HA Sustainable Infrastructure Capital at US$36.75 is still reasonably priced after its recent run, the next sections break down what the current share price might be implying about value. The stock has returned 0.9% over the last 7 days, 0.6% over the past month, 15.5% year to date and 33.8% over the last year, while the 3 year return sits at 53.5% and the 5 year return at a 13.7% decline. These mixed returns over different time frames give important context,...

Wondering whether Teradyne at around US$296 a share still makes sense for your portfolio, or if the story is already priced in? The stock has seen a 42.8% return year to date and a 260.2% return over the last year, even with a 7.4% pullback over both the past week and past month. Recent market attention has focused on Teradyne as part of wider interest in semiconductor and automation related names, where expectations and sentiment can shift quickly. News around sector demand, capital...

AIRO Group Holdings (AIRO) has just wrapped up FY 2025 with fourth quarter revenue of about US$48.3 million, a small net loss of roughly US$0.04 million and basic EPS close to flat at US$0.00. Trailing twelve month revenue came in at about US$90.9 million with a net loss of around US$4.1 million and basic EPS of a US$0.17 loss. Over recent periods the company has reported quarterly revenue of US$23.7 million in Q4 2024, US$11.8 million in Q1 2025, US$24.6 million in Q2, US$6.3 million in Q3...

Bank of America (NYSE:BAC) introduced the Royal ONE Visa Signature and Royal ONE Plus Visa Signature credit cards through a new partnership with Royal Caribbean Group. The new tri branded cards are tied to Royal Caribbean International, Celebrity Cruises, and Silversea, with loyalty rewards that can be used across all three cruise brands. The launch positions Bank of America to deepen its role in travel and leisure financial services and broaden its co branded credit card offering. For Bank...

Jim Cramer recently questioned Freeport-McMoRan’s (NYSE:FCX) copper outlook, flagging concerns about peaking demand and slower growth in China. Cramer also expressed caution on NYSE:FCX as an investment in the near term, highlighting sentiment risks that may sit apart from underlying fundamentals. Separately, long-serving director Robert W. Dudley has announced he will not stand for re-election to the board, opening the door to a future refresh of board composition. Freeport-McMoRan is a...

Lemonade, Inc. was recently added to the NASDAQ Internet Index and was discussed on CNBC’s Mad Money, where Jim Cramer highlighted its AI-driven business model and shrinking losses in a tougher macro backdrop. This combination of index recognition and mainstream media attention is drawing fresh focus to Lemonade’s use of artificial intelligence to reshape its insurance operations and financial profile. Next, we’ll examine how this increased attention to Lemonade’s AI-driven growth and...

CVS Health (CVS) is in focus after opening its first pharmacy-only, apothecary-style location in Chicago, the initial step in a plan for nearly 20 similar sites this year. See our latest analysis for CVS Health. At a share price of US$71.82, CVS Health has seen a 10.1% 30 day share price decline and a 10.4% year to date share price decline. Its 1 year total shareholder return of 9.7% points to longer term gains even as investors weigh new pharmacy formats against the recent legal and...

If you are wondering whether StoneX Group at around US$80.65 is offering value or asking too much, you are not alone. This article is built to help you frame that question clearly. The stock has returned 8.8% over the last 7 days, while the 30 day return is a 5.1% decline. On a longer view, the year to date return is 24.2% and the 1 year return is 58.2%, with very large gains over 3 and 5 years. Recent trading interest has been shaped by ongoing attention on capital markets and financial...

A Los Angeles jury’s decision against Meta Platforms (META) for deliberately designing addictive features that harmed a young user has pushed legal and regulatory risk to the forefront of the Meta stock story. See our latest analysis for Meta Platforms. The Los Angeles verdict has landed against a backdrop of weaker recent performance. The 30 day share price return is 11.73% and the year to date share price return is 12.04%. By contrast, the 3 year total shareholder return of 168.54% and 5...